Clinical-stage company developing gene therapies for severe genetic and rare diseases.
Issues related to value-based payment over time.  Monitored issues related to P.L. 117-2, the American Rescue Plan. Monitored FY'21 Budget Resolution. Monitored issues related to FDA approval of breakthrough therapies. Monitored P.L. 117-2, the American Rescue Plan. Issues related to value based payment over time. Issues related to rulemaking supporting VBP arrangements. Monitored issues related to P.L. 117-2, the American Rescue Plan, as it relates to drug pricing.
GOV - Government Issues BUD - Budget/Appropriations HCR - Health Issues MMM - Medicare/Medicaid
136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
GREG D'ANGELO EMILY PORTER GREG D'ANGELO (White House Office of Management and Budget, Associate Director of Health Programs; Senate Committee on the Budget (Sen. Gregg, Sen. Sessions, and Sen. Enzi), Professional Staff Member.) EMILY PORTER EMILY PORTER
White House Office of Management and Budget, Associate Director of Health Programs; Senate Committee on the Budget (Sen. Gregg, Sen. Sessions, and Sen. Enzi), Professional Staff Member.